Prognostic relevance and validation of ARPC1A in the progression of low-grade glioma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Prognostic relevance and validation of ARPC1A in the progression of low-grade glioma

Published:2024-06-19 Issue:14 Volume:16 Page:11162-11184
ISSN:1945-4589
Container-title:Aging
language:en
Short-container-title:Aging

Author:

Dai Jingyuan¹,Gao Jiahui²,Dong Hongchao³

Affiliation:

1. School of Computer Science and Information Systems, Northwest Missouri State University, Missouri, MO 64468, USA

2. Cangzhou Hospital of Integrated Traditional Chinese and Western Medicine, Hebei, China

3. Shaanxi Second People’s Hospital, Shaanxi, China

Publisher

Impact Journals, LLC

Reference65 articles.

1. Commentary on Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial (Lancet Oncol. 2009;10:459-466).;Linz;Cancer,2010

2. Survival in glioblastoma: a review on the impact of treatment modalities.;Corrales-García;Clin Transl Oncol,2016

3. Treatment of Human Glioblastoma with a Live Attenuated Zika Virus Vaccine Candidate.;Qin;mBio,2018

4. SLC39A1 contribute to malignant progression and have clinical prognostic impact in gliomas.;Peng;Cancer Cell Int,2020

5. Prognostic significance of age related genes in patients with lower grade glioma.;Cao;J Cancer,2020

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP